Vimarsana
Biggest News Aggregation in the World

Page 4 - Hal Barron News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hal Barron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hal Barron Today - Breaking & Trending Today

GSK : announces Wendy Becker to join the Board as Non-Executive Director -September 27, 2023 at 10:40 am EDT - Vimarsana News

GSK : announces Wendy Becker to join the Board as Non-Executive Director -September 27, 2023 at 10:40 am EDT

For media and investors only Issued: London UK GSK plc has today announced that Wendy Becker will join the Board of the Company as a Non-Executive Director with...

GSK : announces Wendy Becker to join the Board as Non-Executive Director - Form 6-K -September 27, 2023 at 10:54 am EDT - Vimarsana News

GSK : announces Wendy Becker to join the Board as Non-Executive Director - Form 6-K -September 27, 2023 at 10:54 am EDT

GSK announces Wendy Becker to join the Board as Non-Executive Director GSK plc has today announced that Wendy Becker will join the Board of the Company as a...

GSK plc (LON:GSK) Receives GBX 1,560 Consensus Target Price from Brokerages - Vimarsana News

GSK plc (LON:GSK) Receives GBX 1,560 Consensus Target Price from Brokerages

Shares of GSK plc (LON:GSK – Get Free Report) have been assigned an average rating of “Hold” from the eight research firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the […]

GSK's (GSK) "Equal Weight" Rating Reiterated at Barclays - Vimarsana News

GSK's (GSK) "Equal Weight" Rating Reiterated at Barclays

GSK (LON:GSK – Get Free Report)‘s stock had its “equal weight” rating restated by analysts at Barclays in a research note issued on Monday, MarketBeat.com reports. They presently have a GBX 1,450 ($18.28) price target on the stock. Barclays‘s price target indicates a potential upside of 5.52% from the stock’s previous close. Several other analysts […]

Source: wkrb13.com
The boom of the anti-aging market: How to get people to live to be 120 (and in good health) - Vimarsana News

The boom of the anti-aging market: How to get people to live to be 120 (and in good health)

This thriving industry — which aims to reverse or delay age-related disease — will be worth around $610 billion globally by 2025

Source: elpais.com